The Role of I-131 MIBG cardiac scintigraphy in diagnosing dementia with lewy bodies : A case report
- Author:
Matthew Stephen L. Jatic
1
;
Eduardo Erasto S. Ongkeko
1
Author Information
1. Division of Nuclear Medicine and PET Center , St. Lukes Medical Center - Bonifacio Global City
- Publication Type:Journal Article
- MeSH:
3-Iodobenzylguanidine;
Lewy Body Disease;
Radionuclide Imaging
- From:
The Philippine Journal of Nuclear Medicine
2021;16(1):26-35
- CountryPhilippines
- Language:English
-
Abstract:
The objective of this case report is to highlight the role of Iodine-131 metaiodobenzylguanidine (MIBG) cardiac
scintigraphy in discriminating Dementia with Lewy Bodies (DLB) from other neurodegenerative diseases such as
Alzheimer’s Disease. This patient is a known case of Parkinson’s disease and has been treated as such since
2011. However, the patient also concurrently deals with visual hallucinations and because of this, the patient’s
attending neurologist wanted to rule in the diagnosis of DLB rather than AD. Hence, an I-131 MIBG cardiac scan
was requested in order to support the diagnosis of DLB. The use of I-131 MIBG cardiac scintigraphy as a
diagnostic tool for diagnosing Lewy Body Dementia is not prevalent and to our knowledge, this was the first
time in the country that this procedure was done (December 9, 2019).
- Full text:The Role of I-131.pdf
